Summary

Rapid Separation and Display of Active Fibrinogenolytic Agents in Sipunculus nudus through Fibrinogen-Polyacrylamide Gel Electrophoresis

Published: April 19, 2024
doi:

Summary

Here, we present a fibrinogen-polyacrylamide gel electrophoresis (PAGE) protocol to rapidly separate and display the fibrinogenolytic agents of Sipunculus nudus.

Abstract

Fibrinogenolytic agents that can dissolve fibrinogen directly have been widely used in anti-coagulation treatment. Generally, identifying new fibrinogenolytic agents requires the separation of each component first and then checking their fibrinogenolytic activities. Currently, polyacrylamide gel electrophoresis (PAGE) and chromatography are mostly used in the separating stage. Meanwhile, the fibrinogen plate assay and reaction products based PAGE are usually adopted to display their fibrinogenolytic activities. However, because of the spatiotemporal separation of those two stages, it is impossible to separate and display the active fibrinogenolytic agents with the same gel. To simplify the separating and displaying processes of fibrinogenolytic agent identification, we constructed a new fibrinogen-PAGE method to rapidly separate and display the fibrinogenolytic agents of peanut worms (Sipunculus nudus) in this study. This method includes fibrinogen-PAGE preparation, electrophoresis, renaturation, incubation, staining, and decolorization. The fibrinogenolytic activity and molecular weight of the protein can be detected simultaneously. According to this method, we successfully detected more than one active fibrinogenolytic agent of peanut wormhomogenate within 6 h. Moreover, this fibrinogen-PAGE method is time and cost-friendly. Furthermore, this method could be used to study the fibrinogenolytic agents of the other organisms.

Introduction

In recent years, due to the continued rise of thrombotic diseases, thrombotic diseases have become a new major global health problem1. At present, antithrombotic drugs are classified into three groups: anti-platelet aggregation drugs, anticoagulants, and thrombolytic drugs. Among them, thrombolytic drugs, such as urokinase (UK), tissue plasminogen activator (tPA), etc., are the only clinically used drugs that can hydrolyze thrombus2. Meanwhile, more safe and effective thrombolytic drugs are being developed by the identification of novel thrombolytic agents3.

However, the identification of novel thrombolytic agents is time-consuming and labor-intensive, which mainly involves the separation/purification and characterization/checking stages. The former is to separate each component, and the latter is to display their fibrino(geno)lytic activities4,5. In previous studies, despite the fact we have successfully isolated a novel fibrino(geno)lytic enzyme (sFE) from the peanut worm (Sipunculus nudus) by affinity chromatography and fibrin(ogen) plate assay6,7,8, these processes are such time and labor-consuming. First, it is necessary to determine whether the peanut worm homogenates have fibrino(geno)lytic activity by the fibrin(ogen) plate method and reaction products based on PAGE9. Then, a series of chromatography, such as ion exchange chromatography, gel filtration chromatography, affinity chromatography, and other methods, have to be carried out for separation and purification10,11. Subsequently, the fibrin plate assay is performed again to check the fibrinogenolytic activity of each separated component. Finally, native-PAGE and sodium dodecyl sulfate (SDS)-PAGE are performed to determine the molecular weight of the active fibrinogenolytic agents12. Therefore, it is critical to rapidly separate and display the active fibrinogenolytic agents.

To rapidly separate and display the active fibrinogenolytic agents in the peanut worm homogenates, a new fibrinogen-PAGE method was developed by combining the PAGE and fibrinogen plate methods, i.e., the substrates of fibrinogenolytic agents fibrinogen were added to the native-PAGE gel. After native-PAGE, the components were separated by their molecular weight. Meanwhile, each active fibrinogenolytic component can be displayed by staining. By this method, we successfully detected more than one active fibrinogenolytic agent of peanut worm homogenate within 6 h. Moreover, this fibrinogen-PAGE method is time and cost-friendly. Furthermore, this method could be used to study the fibrinogenolytic agents of the other organisms.

Protocol

1. Peanut worm homogenate preparation Add 50 g of peanut worms and 150 mL of saline solution into the homogenizer. Homogenize at 24000 rpm for 60 s. NOTE: Repeat 3 times. Centrifuge the homogenate at 9710 x g for 30 min at 4 °C. Collect the supernatant as the peanut worm homogenate for further study. 2. Fibrinogen-PAGE gel preparation Weigh 0.01 g of fibrinogen into a 50 mL glass…

Representative Results

After electrophoresis, all the bands of the marker were clearly displayed. The 1x SDS-PAGE loading lanes only showed 10 kDa bands (bromophenol blue). The sFE and peanut worm samples did not show any observable bands (Figure 1). Although the bands of the samples are not visible, the performance of the marker and bromophenol blue indicated that the electrophoresis was successful, and the samples were separated according to their molecular weight. Although the whole …

Discussion

sFE is a novel fibrino(geno)lytic enzyme isolated from peanut worms by our team previously3,6,8,13. However, the identification processes of sFE were time- and labor-consuming, involving the fibrinogenolytic activity detection, protein components separation, and activity confirmation stages. As a simple method, fibrinogen plate assay is mostly used in the preliminary screening stage to check th…

Divulgations

The authors have nothing to disclose.

Acknowledgements

This research was funded by the Science and Technology Bureau of Xiamen City (No. 3502Z20227197), the Science and Technology Bureau of Fujian Province (No. 2019J01070; No. 2022J01311), and High-level Talents Innovation and Entrepreneurship Project of Quanzhou Science and Technology Plan (No. 2022C015R). We thank Fucai Wang (Huaqiao University) and Lei Tong (Huaqiao University) for their technical assistance.

Materials

1  M Tris-HCl (pH 6.8) Solarbio T1020
1.5 M Tris-HCl (pH 8.8) Solarbio T1010
30% Acrylamide/Bis-acrylamide Biosharp BL513B
Ammonium persulfate XiLONG SCIENTIFIC 7727-54-0
Beaker PYREX 2-9425-02
Centrifuge Tube (1.5 mL) Biosharp BS-15-M
Constant Temperature Incubator JINGHONG JHS-400
Coomas Brillant Blue Stainning solution Beyotime P0017F
Electronic Analytical Balance DENVER TP-213
Fibrinogen Solarbio F8051
Gel loading pipette tips, Bulk Biosharp BS-200-GTB
Homogenizer AHS ATS-1500
Horizontal rotation oscillator NuoMi NMSP-600
Milli-Q Reference Millipore Z00QSV0CN
Mini-PROTEAN Tetra Cell BIO-RAD 165-8000~165-8007
N,N,N',N'-Tetramethylethylenediamine Sigma T9281
Pipette Tip (1 mL) Axygene T-1000XT-C
Pipette Tip (10 µL) Axygene T-10XT-C
Pipette Tip (200 µL) Axygene T-200XT-C
Pipettor (1 mL) Thermo Fisher Scientific ZY18723
Pipettor (10µL) Thermo Fisher Scientific ZX98775
Pipettor (200 µL) Thermo Fisher Scientific ZY20280
Pipettor (50 µL) Thermo Fisher Scientific ZY15331
Refrigerated Centrifuge cence H1650R
Sodium dodecyl sulfate Sigma-Aldrich V900859
Tris Solarbio T8060
Tris-HCl Solarbio T8230
Triton X-100 Solarbio T8200

References

  1. Bikdeli, B., et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 75 (23), 2950-2973 (2020).
  2. Tsivgoulis, G., et al. Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol. 22 (5), 418-429 (2023).
  3. Tang, M., Hu, C., Lin, H., Yan, H. Fibrinolytic drugs induced hemorrhage: mechanisms and solutions. Blood Coagul Fibrinolysis. 34 (5), 263-271 (2023).
  4. Lu, M., et al. Purification, characterization, and chemical modification of Bacillus velezensis SN-14 fibrinolytic enzyme. Int J Biol Macromol. 177, 601-609 (2021).
  5. Abu-Tahon, M. A., Abdel-Majeed, A. M., Ghareib, M., Housseiny, M. M., Abdallah, W. E. Thrombolytic and anticoagulant efficiencies of purified fibrinolytic enzyme produced from Cochliobolus hawaiiensis under solid-state fermentation. Biotechnol Appl Biochem. 70 (6), 1954-1971 (2023).
  6. Lin, W., Lin, H., Xin, P., Yan, H., Kang, B., Tang, M. A Comprehensive approach to analyze the cell components of cerebral blood clots. J Vis Exp. (197), e65791 (2023).
  7. Tang, M., Lin, H., Hu, C., Yan, H. Affinity purification of a fibrinolytic enzyme from Sipunculus nudus. J Vis Exp. (196), e65631 (2023).
  8. . Plasmin affinity purification method based on agarose gel and plasmin and application thereof Available from: https://patents.google.com/patent/CN116103270A/en?oq=CN202310108470 (2023)
  9. Walton, P. L. An improved fibrin plate method for the assay of plasminogen activators. Clinica Chimica Acta. 13 (5), 680-684 (1966).
  10. Ngere, J. B., Ebrahimi, K. H., Williams, R., Pires, E., Walsby-Tickle, J., McCullagh, J. S. O. Ion-exchange chromatography coupled to mass spectrometry in life science, environmental, and medical research. Anal Chem. 95 (1), 152-166 (2023).
  11. Kato, S., Takeuchi, K., Iwaki, M., Miyazaki, K., Honda, K., Hayashi, T. Chitin- and streptavidin-mediated affinity purification systems: A screening platform for enzyme discovery. Angew Chem Int Ed Engl. 62 (31), e202303764 (2023).
  12. Sharma, N., Sharma, R., Rajput, Y. S., Mann, B., Singh, R., Gandhi, K. Separation methods for milk proteins on polyacrylamide gel electrophoresis: Critical analysis and options for better resolution. International Dairy Journal. 114, 104920 (2021).
  13. . Preparation and application of natural fibrinolytic enzyme from peanut worm Available from: https://patents.google.com/patent/CN109295042A/en (2019)
This article has been published
Video Coming Soon
Keep me updated:

.

Citer Cet Article
Kang, B., Hu, C., Lin, H., Yan, H., Wei, C., Tang, M. Rapid Separation and Display of Active Fibrinogenolytic Agents in Sipunculus nudus through Fibrinogen-Polyacrylamide Gel Electrophoresis. J. Vis. Exp. (206), e66536, doi:10.3791/66536 (2024).

View Video